Lovell Government Services will partner with DefEYE Inc., a maker of ophthalmic-biologic products, to serve federal health care systems including the Veterans Health Administration, the Department of Defense Military Health System, and the Indian Health Service. According to a press release from DefEYE, Lovell will act as the company’s Service-Disabled Veteran-Owned Small Business vendor to serve these customers through federal contracting systems.

 

DefEYE’s Biovance 3L Ocular and Biovance are the only decellularized basement membranes used to elevate the management of ocular surface disease and ocular surgery, the company said in the press release.

 

“By making DefEYE’s Biovance ocular portfolio available through our contract vehicles, we streamline practitioner and hospital acquisition, help agencies meet SDVOSB goals, and most importantly, expand access to eyecare innovations that help preserve and restore vision for the veterans we serve,” said Chris Lovell, Major, USMC (Ret.), chief executive officer of Lovell Government Services.